Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
One-day vs five-day octreotide infusion with endoscopic therapy for prevention of early rebleeding and mortality from esophageal varices
TCTR20221004008Phase 4Unknown
- Sponsor
- Phramongkutklao Hospital
- Start
- Sep 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of octreotide in esophageal varices, sponsored by Phramongkutklao Hospital. Status: unknown.
02
Drugs
octreotide
03
Conditions
esophageal varices
Beyond the preview
Go deeper on TCTR20221004008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221004008.